Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Launches Expression-Ready Human Gene Clones Product

Premium

CARLSBAD, Calif.--Invitrogen announced the launch of more than 500 expression-ready human gene clones as a part of its GeneStorm product line, designed to save laboratory research time to speed drug discovery, diagnostic development, and other biotechnology efforts.

The company said it plans to make more than 1,000 expression-ready human gene vectors available by the end of 1998.

The human GeneStorm collection currently consists of more than 100 recombinant kinases and human transcription factors, receptors, and other full-length open reading frames. Each gene is cloned into a versatile state-of-the-art mammalian expression vector with a polyhistidine sequence purification feature in addition to a simplified epitope tag detection feature, to facilitate functional genomics and gene analysis studies. The company first introduced GeneStorm in February with the entire 6,000-gene yeast genome in two expression-ready vector formats.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.